This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pharma Clinical Trial Services: World Market 2013-2023

Catalent

Center for Biologics Evaluation and Research (CBER) [US]

CenterWatch

Central Drugs Standard Control Organization (CDSCO) [ India]

Charles River Laboratories

Chinese Ministry of Commerce

Clinical Trial Support

Clinigene International

Clinipace Worldwide

ClinStar

CMIC

CMIC ( Beijing) Co

CNS Healthcare

CNS Vital Signs

Cogtest (part of The Cognition Group)

Corex Pharmaceutical

Council for International Organizations of Medical Sciences (CIOMS)

Cromos Pharma

Czura Thornton

Dako (part of Agilent Technologies)

Department of Health [UK]

Drug Controller General of India (DCGI)

Eisai

Ekam Imaging

Eli Lilly

European Commission

European Federation of Pharmaceutical Industries and Associations (EFPIA)

European Medicines Agency (EMA)

European Parliament

Firecrest Clinical (part of ICON)

Food and Drug Administration (US FDA)

GCP ClinPlus

GE Healthcare

Genstar Capital

Global CNS Research

Global Research Services (GRS)

GSK

Hellman & Friedman

i3 Research (part of inVentiv Health)

ICON

INC Research

Infociencia (part of RPS)

Innovative Medicines Initiative (IMI)

Inspire

Institute for Medical Research Management and Biometrics (IMEREM, part of RPS)

Integrium

International Cancer Genome Consortium

International Conference of Harmonisation (ICH)

inVentiv Health

J&J

Japan Pharmaceutical Manufacturers Association (JPMA)

Java Clinical

Julphar

Kendle (part of INC Research)

Kforce

Kforce Clinical Research (KCR, part of inVentiv Health)

Kinship Technologies (part of PRA)

Korea Drug Development Fund (KDDF)

Korea Food and Drug Administration (KFDA)

Korea National Enterprise for Clinical Trials (KoNECT)

Kun Tuo (part of Quintiles)

LSK Global

MAB Discovery

Malaysian Biotechnology Corporation

Maximax Pharmaceutical Research

MDS Pharma Services (part of INC Research)

MedAvante

Medelis

Medicines and Healthcare products Regulatory Agency (MHRA) [UK]

Medidata Solutions

Medipal Holdings

Medivation

Merck & Co.

Merck KGaA

Metabolon

MetricStream

Ministry of Health, Labor and Welfare (MHLW, Japan)

Molecular Neuroimaging

Myriad Genetics

National Cancer Institute (NCI) [US]

National Taiwan University Hospital (NTUH)

Nautic Partners

Neuroimage

12 of 13

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,410.23 +218.86 1.27%
S&P 500 2,015.68 +13.52 0.68%
NASDAQ 4,668.4640 +30.47 0.66%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs